Some mammals, including primates, express dominant restriction factors that block the infection of certain retroviruses during the early phase of virus replication. TRIM51 or, in some species, a TRIM5- cyclophilin A fusion protein called TRIMCyp, mediates these early blocks by binding the retroviral capsid as it enters the host cell cytoplasm. TRIM51 is a member of the tripartite motif (TRIM) family of proteins and contains RING, B-box 2, coiled coil and B30.2/SPRY domains. The coiled coil contributes to TRIM51 dimerization;the B30.2/SPRY domain contributes to capsid recognition. The functions of the RING and B-box 2 domains in TRIM51-mediated retroviral restriction are less well understood. These domains contribute to the potency of retrovirus restriction, which is thought to involve the accelerated uncoating the viral capsid. The overall goal of this competing renewal application is to understand the molecular mechanism of TRIM51- mediated retrovirus restriction and to define the roles of individual TRIM51 domains and capsid elements in virus recognition and inhibition.
The specific aims of this proposal are: 1) To investigate the role of the TRIM51 B-box 2 domain in retrovirus restriction;2) To investigate the contribution of the E3 ubiquitin ligase activity of the TRIM51 RING domain to retrovirus restriction;3) To test mechanistic models of TRIM51-mediated retrovirus restriction;and 4) To define how changes in the retroviral capsid influence interaction with TRIM51 and host cell cofactors such as cyclophilin A.

Public Health Relevance

The cells of many mammals, including humans, express TRIM51 proteins that can block infection by retroviruses, including human immunodeficiency virus (HIV-1). The proposed work will attempt to understand how TRIM51 works and how its activity can be improved.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
AIDS Molecular and Cellular Biology Study Section (AMCB)
Program Officer
Sharma, Opendra K
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Dana-Farber Cancer Institute
United States
Zip Code
Fernández-Oliva, Alberto; Finzi, Andrés; Haim, Hillel et al. (2016) HIV-1 Adapts To Replicate in Cells Expressing Common Marmoset APOBEC3G and BST2. J Virol 90:725-40
Pacheco, Beatriz; Menéndez-Arias, Luis; Sodroski, Joseph (2016) Characterization of two distinct early post-entry blocks to HIV-1 in common marmoset lymphocytes. Sci Rep 6:37489
Zhang, Shijian; Sodroski, Joseph (2015) Efficient human immunodeficiency virus (HIV-1) infection of cells lacking PDZD8. Virology 481:73-8
Guth, Charles Alexander; Sodroski, Joseph (2014) Contribution of PDZD8 to stabilization of the human immunodeficiency virus type 1 capsid. J Virol 88:4612-23
Tipper, Christopher; Sodroski, Joseph G (2014) Contribution of glutamine residues in the helix 4-5 loop to capsid-capsid interactions in simian immunodeficiency virus of macaques. J Virol 88:10289-302
Tipper, Christopher; Sodroski, Joseph (2013) Enhanced autointegration in hyperstable simian immunodeficiency virus capsid mutants blocked after reverse transcription. J Virol 87:3628-39
Li, Xing; Kim, Jonghwa; Song, Byeongwoon et al. (2013) Virus-specific effects of TRIM5?(rh) RING domain functions on restriction of retroviruses. J Virol 87:7234-45
Diaz-Griffero, Felipe; Gallo, Daniel E; Hope, Thomas J et al. (2011) Trafficking of some old world primate TRIM5? proteins through the nucleus. Retrovirology 8:38
Ganser-Pornillos, Barbie K; Chandrasekaran, Viswanathan; Pornillos, Owen et al. (2011) Hexagonal assembly of a restricting TRIM5alpha protein. Proc Natl Acad Sci U S A 108:534-9
Kar, Alak K; Mao, Youdong; Bird, Gregory et al. (2011) Characterization of a core fragment of the rhesus monkey TRIM5? protein. BMC Biochem 12:1

Showing the most recent 10 out of 43 publications